Biblio
] Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group. Lancet Haematol. 2020.
CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiation. Br J Haematol. 2018.